Brief: Blue Vision Signes Term Sheet Regarding Potential Acquisition Of Two Companies
Dec 18 (Reuters) - Blue Vision A/S BLVISa.CO :
* SIGNES TERM SHEET REGARDING POTENTIAL ACQUISITION OF TWO
COMPANIES
* TOTAL PURCHASE PRICE IS EXPECTED TO AMOUNT TO DKK 17.5
MILLION
* ADDITIONAL POTENTIAL EARN-OUT FOR 2020 AND 2021 TO BE OF
UP TO
DKK 7.5 MILLION
* FOR 2019 SEES REVENUE OD ABOUT DKK 33 MILLION, PRE-TAX
PROFIT OF
DKK 6.8 MILLION
Source text for Eikon: ID:nGNE3kdgh2
Further company coverage: BLVISa.CO
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))
Recent news on Pharma Equity A/S
See all newsBrief: PEG: Interpatium Commences Proceedings To Set Aside Arbitral Award
Brief: Pharma Equity Maintains Financial Guidance For 2026
Brief: Pharma Equity Group Unit Gets Patent Grant Notification
Brief: Pharma Equity Group To Borrow Up To About DKK 9.63 Million
Brief: Pharma Equity Group Adjusts 2025 Expectations